FOXP3 and gastric cancer: The results demonstrated that the knockdown of DNAAF3 led to a decrease in the expression of β-Catenin and its downstream target CCL28 in gastric cancer (Figures 12D, E), resulting in the suppression of Treg cell (FOXP3+) infiltration (Figure 12F).